BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9309380)

  • 1. Animal studies on the endocrinological profile of dienogest, a novel synthetic steroid.
    Katsuki Y; Sasagawa S; Takano Y; Shibutani Y; Aoki D; Udagawa Y; Nozawa S
    Drugs Exp Clin Res; 1997; 23(2):45-62. PubMed ID: 9309380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile.
    Sasagawa S; Shimizu Y; Kami H; Takeuchi T; Mita S; Imada K; Kato S; Mizuguchi K
    Steroids; 2008 Feb; 73(2):222-31. PubMed ID: 18061638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins.
    Katsuki Y; Shibutani Y; Aoki D; Nozawa S
    Cancer; 1997 Jan; 79(1):169-76. PubMed ID: 8988742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The endocrinologic profile of metabolites of the progestin dienogest].
    Oettel M; Kaufmann G; Kurischko A
    Pharmazie; 1993 Jul; 48(7):541-5. PubMed ID: 8415850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression.
    Shimizu Y; Takeuchi T; Mita S; Mizuguchi K; Kiyono T; Inoue M; Kyo S
    Mol Hum Reprod; 2009 Oct; 15(10):693-701. PubMed ID: 19502247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro.
    Okada H; Nakajima T; Yoshimura T; Yasuda K; Kanzaki H
    Mol Hum Reprod; 2001 Apr; 7(4):341-7. PubMed ID: 11279296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacology of dienogest.
    Ruan X; Seeger H; Mueck AO
    Maturitas; 2012 Apr; 71(4):337-44. PubMed ID: 22364708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dienogest on surgically induced endometriosis in rats after repeated oral administration.
    Fischer OM; Kaufmann-Reiche U; Moeller C; Fuhrmann U
    Gynecol Obstet Invest; 2011; 72(3):145-51. PubMed ID: 21985956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats.
    Katsuki Y; Takano Y; Futamura Y; Shibutani Y; Aoki D; Udagawa Y; Nozawa S
    Eur J Endocrinol; 1998 Feb; 138(2):216-26. PubMed ID: 9506869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].
    Oettel M; Carol W; Gräser T; Klinger G; Mellinger U; Moore C; Schindler AE; Winkler UH
    Zentralbl Gynakol; 1997; 119(12):597-606. PubMed ID: 9483810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of estradiol valerate/dienogest.
    Teichmann A
    Climacteric; 2003 Aug; 6 Suppl 2():17-23. PubMed ID: 14669840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.
    Papp C; Schatz F; Krikun G; Hausknecht V; Lockwood CJ
    Early Pregnancy (Cherry Hill); 2000 Oct; 4(4):230-9. PubMed ID: 11742418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose pilot study with the novel progestogen dienogestin patients with endometriosis.
    Schindler AE; Christensen B; Henkel A; Oettel M; Moore C
    Gynecol Endocrinol; 2006 Jan; 22(1):9-17. PubMed ID: 16522528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial.
    Strowitzki T; Marr J; Gerlinger C; Faustmann T; Seitz C
    Hum Reprod; 2010 Mar; 25(3):633-41. PubMed ID: 20089522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Steroid receptors in the gestagen treatment of endometriosis].
    Seliger E; Kaltwasser P; Schneider F; Rothe K; Buchmann J
    Ther Umsch; 1990 Dec; 47(12):945-50. PubMed ID: 2096479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovulation-inhibiting effects of dienogest in a randomized, dose-controlled pharmacodynamic trial of healthy women.
    Klipping C; Duijkers I; Remmers A; Faustmann T; Zurth C; Klein S; Schuett B
    J Clin Pharmacol; 2012 Nov; 52(11):1704-13. PubMed ID: 22128200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiprogestins: mechanism of action and contraceptive potential.
    Spitz IM; Croxatto HB; Robbins A
    Annu Rev Pharmacol Toxicol; 1996; 36():47-81. PubMed ID: 8725382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dienogest.
    Foster RH; Wilde MI
    Drugs; 1998 Nov; 56(5):825-33; discussion 834-5. PubMed ID: 9829156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dienogest: a review of its use in the treatment of endometriosis.
    McCormack PL
    Drugs; 2010 Nov; 70(16):2073-88. PubMed ID: 20964453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.